Pfizer CEO warns German investment at risk over drug pricing policies

Pfizer Inc.

Pfizer Inc.

PFE

0.00

LONDON/FRANKFURT, June 10 (Reuters) - Pfizer PFE.N CEO Albert Bourla said in a letter to German Chancellor Friedrich Merz that the drugmaker is reviewing the timing and scope of planned investments in the country, citing the government's policy proposals that would lower drug prices.

The letter, dated June 9 and seen by Reuters on Wednesday, was first reported by German business newspaper Handelsblatt.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.